Global Transcatheter Embolization and Occlusion Devices Market to Expand at 8.66% CAGR as Demand for Minimally Invasive Vascular and Cancer Therapies Accelerates.
Austin, Texas, Jan. 27, 2026 (GLOBE NEWSWIRE) — Transcatheter Embolization and Occlusion Devices Market Size & Growth Analysis:
According to SNS Insider, the Transcatheter Embolization and Occlusion Devices Market was valued at USD 5.93 billion in 2025 and is projected to reach USD 11.53 billion by 2033, expanding at a compound annual growth rate (CAGR) of 8.66% during the forecast period 2026–2033. The market is witnessing sustained growth due to increasing adoption of minimally invasive interventional procedures across oncology, neurology, and peripheral vascular applications.
Market Size and Forecast:
- Market Size in 2025: USD 5.93 Billion
- Market Size by 2033: USD 11.53 Billion
- CAGR: 8.66% from 2026 to 2033
- Base Year: 2025
- Forecast Period: 2026–2033
- Historical Data: 2022–2024
Get a Sample Report of Transcatheter Embolization and Occlusion Devices Market: https://www.snsinsider.com/sample-request/7988
The U.S. Transcatheter Embolization and Occlusion Devices Market was valued at USD 1.71 billion in 2025 and is expected to reach USD 3.23 billion by 2032, growing at a CAGR of 8.28% during the forecast period 2026–2033. Growth in the U.S. is supported by high procedural volumes, early adoption of advanced embolic technologies, favorable reimbursement frameworks, and strong clinical expertise in interventional radiology and neuro-intervention.
Rising Demand for Minimally Invasive Oncology and Neurovascular Procedures Fuels Market Growth
The global market is gaining momentum due to the increasing burden of cancer, cerebrovascular disorders, and trauma-related vascular conditions. Embolization techniques such as transarterial chemoembolization (TACE) and radioembolization (TARE) are becoming standard-of-care treatments for unresectable tumors, while coil and liquid embolization remain critical in managing aneurysms and arteriovenous malformations.
Key growth drivers include:
- Rising prevalence of cancer, aneurysms, and vascular malformations
- Growing preference for minimally invasive and catheter-based procedures
- Technological advancements in embolic materials and delivery systems
- Expanding interventional radiology and neuro-interventional capabilities
- Favorable reimbursement and reduced hospital stay compared to open surgery
Device adoption continues to accelerate as hospitals and specialty centers seek solutions that offer higher precision, reduced complication rates, and faster patient recovery.
Segmentation Analysis:
By Device Type
The non-coil segment dominated the transcatheter embolization and occlusion devices market share with 51.4% in 2025, as it has wide applicability compared to other products, contributing the major market share in treating complicated vascular abnormalities and tumors. The coils segment is anticipated to grow steadily during the forecast period, owing to increasing volumes of neurovascular procedures and design refinements in coils over the period.
By Application
The oncology segment dominated the transcatheter embolization and occlusion devices market with a 61.20% market share due to the high standard application of embolization procedures in the treatment of cancer, especially for unresectable tumors. The neurology segment is anticipated to grow at the fastest rate during the forecast period, owing to the increasing prevalence of cerebral aneurysms, strokes, and arteriovenous malformations (AVMs).
By End-Use
The hospitals segment dominated the transcatheter embolization and occlusion devices market in 2025 with a 64.3% market share due to the availability of advanced imaging systems and specialist interventional radiology units. The ambulatory surgical centers (ASCs) segment is projected to register the fastest CAGR during the forecast period, due to the increasing need for cost-effective adult soft tissue surgical procedures with minimum trauma and faster recovery times.
Need Any Customization Research on Transcatheter Embolization and Occlusion Devices Market, Enquire Now: https://www.snsinsider.com/enquiry/7988
Regional Insights:
North America dominated the transcatheter embolization and occlusion devices market with a 38.12% market share in 2025, due to the advanced healthcare infrastructure, broad accessibility of interventional radiology services, and a high incidence of vascular and oncologic conditions.
The transcatheter embolization and occlusion devices market trends in Asia Pacific are anticipated to grow fastest with a 9.25% CAGR owing to increasing healthcare expenditures, a rise in cancer and vascular diseases, and higher availability of advanced medical technologies.
Major Players Analysis Listed in the Transcatheter Embolization and Occlusion Devices Market Report are
- Boston Scientific Corporation
- Medtronic, Inc.
- Stryker Corporation
- Abbott Laboratories
- Cook Medical
- Terumo Corporation
- DePuy Synthes (Johnson & Johnson)
- Cordis Corporation
- St. Jude Medical
- Sirtex Medical
Recent Developments:
- In April 2022, Boston Scientific announced that it had received FDA510(k) clearance for its EMBOLD Fibered Detachable Coil for use in occlusion or embolization of blood vessels within the peripheral vasculature to restrict or block blood flow. With the University of Alabama at Birmingham performing the first clinical procedure earlier this week, the device has achieved an important milestone in peripheral embolization therapy.
Purchase Single User PDF of Transcatheter Embolization and Occlusion Devices Market Report (20% Discount): https://www.snsinsider.com/checkout/7988
Exclusive Sections of the Report (The USPs):
- DISEASE INCIDENCE & PREVALENCE ANALYSIS (2024) – helps you understand the burden of target conditions across major regions, guiding market demand estimation for embolization and occlusion devices.
- REGIONAL EPIDEMIOLOGY INSIGHTS – helps you identify key geographic markets with higher patient volumes, highlighting growth hotspots for interventional radiology and cardiovascular procedures.
- HEALTHCARE SPENDING TRENDS (2024) – helps you analyze funding distribution across government, private, commercial, and out-of-pocket segments influencing medical device adoption rates.
- PUBLIC VS. PRIVATE SECTOR INVESTMENT INDEX – helps you assess the balance of healthcare financing and its direct impact on accessibility and affordability of transcatheter treatments.
- TREATMENT DEMAND FORECAST INDICATORS – helps you correlate disease prevalence with procedural volumes and estimate future demand for embolization and occlusion devices.
- MARKET ACCESS & REIMBURSEMENT INSIGHTS – helps you evaluate how regional healthcare expenditure patterns shape reimbursement opportunities and market penetration strategies.
About the Report
The Transcatheter Embolization and Occlusion Devices Market Report provides comprehensive insights, including:
- Market size and forecasts (2022–2033)
- In-depth segmentation and regional analysis
- Competitive landscape and company profiling
- Technology trends, opportunities, and challenges
- Strategic insights for manufacturers, investors, and healthcare providers
Access Complete Report Details of Transcatheter Embolization and Occlusion Devices Market Analysis & Outlook: https://www.snsinsider.com/reports/transcatheter-embolization-and-occlusion-devices-market-7988
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
CONTACT: Contact Us: Rohan Jadhav - Principal Consultant Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK) Email: [email protected]
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.